SCHEMBL185238

SCHEMBL185238

O=C(Nc1nc2c(s1)CCCC2)C(OC1CCOCC1)c1ccc(S(=O)(=O)C2CC2)cc1

nearest known ligand 0.77

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GCK P35557 20/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL626483 0.92 GCK (0.65) GCK
SCHEMBL11972309 0.87 GCK (1.00) GCK
SCHEMBL11972651 0.87 GCK (0.86) GCK
SCHEMBL11972236 0.85 GCK (0.69) GCK
SCHEMBL11972471 0.85 GCK (0.66) GCK
SCHEMBL626672 0.84 GCK (0.62) GCK
SCHEMBL11972024 0.83 GCK (0.65) GCK
SCHEMBL11972042 0.83 GCK (0.80) GCK
SCHEMBL11972316 0.82 GCK (0.60) GCK
SCHEMBL11971988 0.80 GCK (0.58) GCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2402327-B1 Acetamide compounds as glucokinase activators, their process and medicinal applications IMPETIS BIOSCIENCES LTD (IN) 2018-03-07 EP claimed
EP-2402327-A1 Acetamide compounds as glucokinase activators, their process and medicinal applications Advinus Therapeutics Private Limited (IN) 2012-01-04 EP claimed
EP-2402327-B1 Acetamide compounds as glucokinase activators, their process and medicinal applications IMPETIS BIOSCIENCES LTD (IN) 2018-03-07 EP disclosed